IMAGE MAP, Section8, chapter 2

VISUAL AIDS

Conventions are the same as for all the preceding chapters: S=section, C=chapter, VA=visual aid, and P=pictorial. Labels identified with an “-X” in the MASTERBORDER to the left are textual chapters which, in addition, are parent chapters for one or more pictorials at tier 3. In the following list, there is a brief characterization of pictorials that becomes accessible by clicking on an underlined label.

S8C9VA1a-1: leukocytoclastic vasculitis (photomicrograph)

S8C9VA1-1-7: vasculitis (lists); S8C10VA2-1-9: vasculitis (lists); S8C12VA3-1-7: vasculitis (lists); S8C13VA4-1-4: vasculitis (lists); S8C14VA5-1-7: vasculitis (lists);

S8C24VA6-1-6: (lists); S8C34bVa7b-1-4: vasculitis (lists)

PHOTOMICROGRAPHS

S8C11aP1a-1-7: vasculitis (neutrophilic and histiocytic collagenosis);

S8C11bP1b-1-4:vasculitis (neutrophilic and leukocytoclastic);

S8C11P1-1-8: vasculitis: basic expressions and associated phenomena;

S8C15P2-1-3: Henoch-Schonlein purpura;

S8C15P2-4-9: Behcet’s syndrome;

S8C16P3-1-4: cutaneous polyarteritis nodosa;

S8C16P3-5-7: superficial erosive dermatitis (neurotic excoriation);

S8C16P3-8: livedo vasculitis-like patterns;

S8C17P4-1-7: granuloma faciale;

S8C18P5-1-4: granuloma faciale;

S8C19P6-1-8: erythema elevatum diutinum;

S8C19aP6a-1-4: erythema elevatum diutinum;

S8C19bP6b-1-5: erythema elevatum diutinum;

S8C19cP6c-1-5: erythema elevatum diutinum;

S8C20P7-1-7: Degos’ disease;

S8C21P8-1-4: lymphocytic vasculitis;

S8C22P9-1-5: lymphocytic vasculitis;

S8C22P9-6 & 7: polymorphic light eruption (lymphocytic infiltrate); S8C22aP9a-1-3: polymorphic light eruption;

S8C23P10-1-6: Wegener’s granulomatosis;

S8C25P11-1-3: livedo vasculitis-like patterns;

S8C25P11-4&5: thrombotic thrombocytopenic purpura;

S8C25P11-6: coagulopathy (cryoglobulinemia);

S8C26P12-1-4: thrombotic angiopathy (livedo vasculitis-like patterns);

S8C26P12-5-7: thrombotic angiopathy (anti-phospholipid syndrome);

S8C26aP12a-1-3: senile dermatolysis (variant of senile purpura);

S8C27P13-1-5: acral angiodermatitis; S8C28P14-1-6: acral angiodermatitis;

S8C29P15-1-2: granulation tissue;

S8C30P16-1-5: hyaline angiopathies;

S8C31P17-1-4: hyaline angiopathies (lupus profundus);

S8C32P18-1-5: hyaline angiopathies (erythropoietic protoporphyria);

S8C32P18-6-8: hyaline angiopathies (lipoid proteinosis);

S8C33P19-1-2: angiopathies (scleroderma);

S8C34P20-1-4: neutrophilic collagenosis (Sweet’s syndrome);

S8C34P20-5: neutrophilic collagenosis (pyoderma gangrenosum); S8C34aP20a-1-3; pyoderma gangrenosum;

S8C35P21-1-4: calcifying panniculitis (calciphylaxis);

S8C35P21-5-7: Kawasaki’s disease;

S8C36P22-1-8:Wegener’s granulomatosis; S8C36aP22a-1-3: Wegener’s granulomatosis;

S8C37P23-1-4: giant cell arteritis (temporal arteritis);

S8C37P23-5-7: Buerger’s disease (thromboangiitis obliterans);

S8C38P24-1-3: temporal (giant cell) arteritis;